文献速递甲状腺核医学

自身免疫性甲状腺疾病

Autoimmune Thyroid Diseases.
PubMed 文献 · Semin Nucl Med · 2023-12-02

自身免疫性甲状腺疾病(AITDs)以Graves病和桥本甲状腺炎/自身免疫性甲状腺炎最常见,也包括无痛性和产后甲状腺炎。放射性碘摄取率和甲状腺显像在鉴别甲状腺毒症与甲状腺功能亢进中起关键作用,甲状腺抗体和超声为补充评估方法。

要点

  • AITDs最常见形式为Graves病和桥本甲状腺炎/自身免疫性甲状腺炎,女性更常见。
  • 放射性碘摄取率和甲状腺显像(99mTc-高锝酸盐或123-I)在鉴别诊断中起关键作用。
  • 甲状腺毒症需与甲状腺功能亢进区分,两者治疗方法不同。

核心结论

  • AITDs包括Graves病、桥本甲状腺炎/自身免疫性甲状腺炎、无痛性和产后甲状腺炎等,Graves病和AIT可在甲状腺功能亢进与减退之间转换,增加鉴别诊断和治疗策略的复杂性。

研究设计与样本

  • 本文为综述,未报告系统检索范围。

主要发现

  • AITDs在女性中比男性更常见,最常见形式为Graves病和桥本甲状腺炎/自身免疫性甲状腺炎。
  • 近十年因酪氨酸激酶抑制剂(TKIs)和免疫检查点抑制剂(ICPIs)广泛使用,AITDs及抗肿瘤分子药物相关的其他炎性甲状腺疾病更常见。
  • SARS-CoV-2感染相关的自身免疫性甲状腺炎是近年新出现的疾病实体。
  • Graves病和AIT可在甲状腺功能亢进与减退之间转换,可能使鉴别诊断和治疗策略复杂化。
  • 所有AITDs均可表现为甲状腺毒症,需与甲状腺功能亢进区分,因治疗方法不同。

关键数值与推荐

  • 放射性碘摄取率(RAIU)和甲状腺显像使用99mTc-高锝酸盐(Na[99mTc]TcO4)或123-I(Na[123I]I),在鉴别诊断中起关键作用。
  • 甲状腺过氧化物酶抗体(TPO)和促甲状腺激素受体抗体(TRAb)检测以及甲状腺超声是评估甲状腺疾病的补充方法。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autoimmune thyroid diseases (AITDs) include a wide spectrum of thyroid diseases affecting more commonly women than men. The most frequent forms are Graves' Disease (GD) and Hashimoto's thyroiditis / Autoimmune Thyroiditis (AIT), but there are also other immunogenic destructive forms of thyroiditis, that is, silent and postpartum thyroiditis. In the last decade, AITDs and other inflammatory thyroid diseases related to anti-tumor molecular drugs are more frequently seen due to the widespread use of tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICPIs). Autoimmune thyroiditis related to SARS-CoV-2 infection has been a novel entity in recent years. Graves' Disease and AIT may shift from hyperthyroidism to hypothyroidism, which may complicate the differential diagnosis and further treatment strategy. Moreover, all AITDs may manifest with thyrotoxicosis (a clinical condition marked with high serum levels of thyroid hormones) which has to be distinguished from hyperthyroidism (increased thyroid hormone production and secretion as a result of hyperfunctioning thyroid gland) due to different therapeutic approaches. Nuclear medicine techniques, such as radioiodine uptake (RAIU) and thyroid scintigraphy, using 99mTc- pertechnetate (Na[99mTc]TcO4) or 123-Iodine (Na[123I]I), have a crucial role in the differential diagnosis. Measurement of thyroid antibodies, e.g. thyroid peroxidase antibodies (TPO) and thyrotropin receptor antibodies (TRAb), as well as thyroid ultrasound, are complementary methods in the evaluation of thyroid disorders.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Petranović Ovčariček P, Görges R, Giovanella L, et al. Autoimmune Thyroid Diseases. Semin Nucl Med. 2023. PMID: 38044176. doi:10.1053/j.semnuclmed.2023.11.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。